SP1 and cancer: Other sub-group II receptors: Among the remaining NRs in this subgroup, testicular receptor 4 (TR4) is the receptor that activates genes (e.g., apoE) in cancer cells, and this involves both TR4 response elements alone and in combination with Sp1 [96].